| Quarterly Financials | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
Revenue  | 9 | 16 | 12 | 16 | 16 | 12 | 10 | 7 | 12 | 15 | 18 | 14 | 17 | 17 | 18 | 18 | 13 | 16 | 11 | 10 | 6 | 6 | 7 | 8 | 6 | 9 | 4 | 9 | 3 |
| Expenses | 10 | 13 | 11 | 13 | 15 | 14 | 12 | 9 | 10 | 11 | 15 | 11 | 14 | 14 | 16 | 17 | 12 | 14 | 9 | 10 | 7 | 6 | 6 | 8 | 7 | 8 | 6 | 7 | 6 |
| EBITDA | -1 | 3 | 1 | 2 | 1 | -2 | -3 | -2 | 2 | 3 | 4 | 3 | 4 | 4 | 2 | 1 | 1 | 3 | 2 | 1 | -1 | 1 | 1 | -1 | -0 | 1 | -2 | 2 | -3 |
| Operating Profit % | -26 % | 18 % | 14 % | 13 % | 5 % | -4 % | -45 % | -52 % | 17 % | 23 % | 20 % | 16 % | 21 % | 20 % | 11 % | -3 % | 5 % | 11 % | 14 % | 4 % | -14 % | 8 % | 8 % | -13 % | -5 % | 5 % | -45 % | -4 % | -126 % |
| Depreciation | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -2 | 3 | 2 | 2 | 1 | -2 | -3 | -1 | 2 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 1 | 2 | 1 | 1 | -1 | 0 | 0 | -1 | -1 | 0 | -2 | 2 | -4 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | -0 | 0 |
| Net Profit | -2 | 3 | 2 | 2 | 1 | -2 | -3 | -1 | 2 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 1 | 2 | -1 | 0 | -1 | 0 | -0 | -1 | -1 | 0 | -2 | 2 | -4 |
| EPS in ₹ | -1.41 | 2.16 | 1.77 | 1.80 | 1.60 | -1.54 | -2.63 | -0.90 | 2.33 | 2.89 | 3.45 | 2.42 | 3.20 | 2.56 | 1.64 | 1.20 | 0.48 | 1.72 | -1.07 | -0.31 | -0.89 | 0.09 | -0.13 | -0.86 | -0.45 | 0.25 | -1.64 | 1.38 | -2.80 |
Medi Caps
Medi Caps
36.00
+0.10
(0.28%)
Key Fundamentals
Market Cap
44.80 Cr
EPS
-0.46
PE Ratio
-12.91
Dividend Yield
0.00 %
Industry
Healthcare 52 Week High
61.00
52 Week Low
34.32
PB Ratio
0.37
Debt to Equity
0.00
Sector
Pharmaceuticals Actual
Company News
View All News
Medi-Caps Limited approved unaudited standalone and consolidated financial results for the quarter ended June 30, 2025. On standalone basis, the company reported a net loss of Rs 39.75 lakhs compared to a profit of Rs 33.17 lakhs in the same quarter last year, with no revenue from operations during the quarter. On consolidated basis, revenue from operations was Rs 268.76 lakhs versus Rs 619.44 lakhs in the previous year quarter, while net loss widened to Rs 349.19 lakhs from Rs 57.10 lakhs. The board scheduled the 42nd Annual General Meeting for September 18, 2025, and approved the appointment of Joshi Sahay and Company as Secretarial Auditor for five years from FY 2025-2026 to FY 2029-2030. The board also approved the re-appointment of Mr. Dharmendra Solanki as Non Executive Independent Director for a second five-year term from February 5, 2026 to February 4, 2031, subject to shareholder approval.
Medi-Caps Limited Re-appoints Dharmendra Solanki as Independent Director for Second Five-Year Term
Aug 05, 2025
Aug 05, 2025Medi-Caps Limited's Board of Directors approved the re-appointment of Mr. Dharmendra Solanki as Non-Executive Independent Director for a second term of five years, from February 5, 2026, to February 4, 2031. The re-appointment is subject to shareholder approval at the company's 42nd Annual General Meeting. Solanki holds a Bachelor's and Master's degree in commerce from Vikram University, Ujjain, and has 27 years of post-qualification experience in accounts, finance, and taxation. The company confirmed that Solanki is not related to any other directors and is not debarred from accessing capital markets by SEBI or any other authority.
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,679.10 | #1 3,98,049.70 | 38.75 | #1 54,729.00 | 9.71 | #1 10,980 | -19.84 | 61.71 | |
6,621.50 | 1,75,222.50 | 76.19 | 9,712.00 | 18.67 | 2,191 | 26.74 | 72.60 | |
1,577.60 | 1,26,768.90 | 23.67 | 28,409.50 | 7.12 | 5,291 | 9.88 | 60.63 | |
3,584.30 | 1,19,599.80 | 60.49 | 11,539.40 | 6.99 | 1,911 | 19.91 | 53.74 | |
1,255.90 | 1,03,508.80 | #1 18.25 | 33,741.20 | 16.73 | 5,725 | 1.26 | 48.97 | |
2,476.60 | 1,01,344.60 | 53.48 | 12,744.20 | #1 20.90 | 2,007 | -18.14 | 47.04 | |
987.65 | 99,073.80 | 21.09 | 23,511.00 | 18.55 | 4,615 | 2.60 | 45.37 | |
1,940.00 | 89,121.90 | 23.79 | 22,909.50 | 13.74 | 3,306 | #1 51.64 | 46.82 | |
5,581.50 | 66,047.70 | 28.61 | 13,458.30 | 3.70 | 2,216 | 21.39 | 63.11 | |
1,101.00 | 64,254.10 | 19.04 | 32,345.60 | 9.43 | 3,484 | -10.24 | 50.87 |
Growth Rate
Revenue Growth
1.44 %
Net Income Growth
-72.73 %
Cash Flow Change
-26.95 %
ROE
-74.59 %
ROCE
-34.31 %
EBITDA Margin (Avg.)
102.53 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 89 | 93 | 97 | 101 | 107 | 95 | 115 | 130 | 126 | 127 | 125 |
| Fixed Assets | 58 | 56 | 62 | 61 | 60 | 57 | 58 | 59 | 59 | 59 | 57 |
| Current Assets | 27 | 32 | 33 | 37 | 42 | 33 | 53 | 67 | 60 | 60 | 53 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 |
| Investments | 2 | 3 | 8 | 11 | 16 | 22 | 29 | 31 | 32 | 38 | 43 |
| Other Assets | 30 | 34 | 27 | 29 | 31 | 15 | 27 | 40 | 35 | 30 | 25 |
| Total Liabilities | 89 | 93 | 97 | 101 | 107 | 95 | 115 | 130 | 126 | 127 | 125 |
| Current Liabilities | 6 | 10 | 7 | 9 | 9 | 3 | 9 | 13 | 6 | 5 | 3 |
| Non Current Liabilities | 2 | 1 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
| Total Equity | 81 | 82 | 89 | 90 | 96 | 91 | 105 | 116 | 119 | 121 | 121 |
| Reserve & Surplus | 69 | 70 | 77 | 78 | 83 | 79 | 92 | 104 | 106 | 109 | 109 |
| Share Capital | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 0 | 1 | 0 | 0 | -1 | 6 | 3 | -9 | -1 | 0 |
| Investing Activities | -7 | -2 | 3 | -4 | -6 | -6 | -10 | -4 | -3 | -8 | -5 |
| Operating Activities | 7 | 3 | 4 | 4 | 6 | 5 | 15 | 7 | -6 | 7 | 5 |
| Financing Activities | 0 | -1 | -6 | 0 | -0 | -0 | -0 | 0 | 0 | 0 | 0 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 50.14 % | 50.14 % | 50.13 % | 50.13 % | 50.13 % | 50.13 % | 50.13 % | 50.13 % | 50.13 % | 50.13 % | 50.13 % | 50.13 % | 50.13 % | 50.13 % | 50.43 % | 50.62 % | 50.77 % | 50.77 % | 50.77 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 47.78 % | 47.23 % | 47.68 % | 47.63 % | 47.66 % | 45.22 % | 45.17 % | 44.91 % | 45.14 % | 44.74 % | 44.41 % | 44.59 % | 44.83 % | 44.60 % | 44.07 % | 44.37 % | 44.57 % | 44.34 % | 44.31 % |
| Others | 2.05 % | 2.60 % | 2.15 % | 2.21 % | 2.18 % | 4.62 % | 4.67 % | 4.93 % | 4.70 % | 5.10 % | 5.43 % | 5.24 % | 5.01 % | 5.24 % | 5.48 % | 4.99 % | 4.63 % | 4.86 % | 4.89 % |
| No of Share Holders | 0 | 4,068 | 4,301 | 4,623 | 4,908 | 18,197 | 17,752 | 16,993 | 15,308 | 14,566 | 13,790 | 13,226 | 12,356 | 11,738 | 11,255 | 11,176 | 11,033 | 10,851 | 10,692 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 26 Sept 2024 |  Annual General Meeting | NA | 26 Sept 2024 | 48.52 | 50.50 |
| 12 Nov 2024 |  Quarterly Result Announcement | NA | 12 Nov 2024 | 54.19 | 50.81 |
| 12 Feb 2025 | Quarterly Result Announcement | NA | 12 Feb 2025 | 49.22 | 46.56 |
| 21 May 2025 | Quarterly Result Announcement | NA | 21 May 2025 | 43.51 | 43.89 |
| 05 Aug 2025 | Quarterly Result Announcement | NA | 05 Aug 2025 | 42.16 | 43.17 |
| 18 Sept 2025 | Annual General Meeting | NA | 18 Sept 2025 | 43.17 | 38.83 |
Announcements
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 07, 2025
Oct 07, 2025Closure of Trading WindowSep 26, 2025
Sep 26, 2025Announcement under Regulation 30 (LODR)-Change in ManagementSep 19, 2025
Sep 19, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 19, 2025
Sep 19, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 18, 2025
Sep 18, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 28, 2025
Aug 28, 2025Information Regarding E-Voting For 42Nd Annual General MeetingAug 26, 2025
Aug 26, 2025 Intimation For Dispatch Of Letter To Those Shareholders Whose E-Mail Addresses Are Not Registered With Company/Registrar & Transfer Agent/Depository ParticipantsAug 26, 2025
Aug 26, 2025Reg. 34 (1) Annual Report.Aug 26, 2025
Aug 26, 2025Submission Of Notice Of Convening 42Nd AGM Of The Company.Aug 26, 2025
Aug 26, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 12, 2025
Aug 12, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 07, 2025
Aug 07, 2025Submission Of Unaudited Standalone & Consolidated Financial Results For The Quarter Ended 30.06.2025Aug 05, 2025
Aug 05, 2025Announcement under Regulation 30 (LODR)-Change in ManagementAug 05, 2025
Aug 05, 2025Announcement under Regulation 30 (LODR)-Change in ManagementAug 05, 2025
Aug 05, 2025Board Meeting Outcome for OUTCOME OF BOARD MEETING HELD ON TUESDAY 05TH AUGUST 2025 PURSUANT TO REGULATION 30 OF SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS 2015.Aug 05, 2025
Aug 05, 2025Board Meeting Intimation for Board Meeting (Serial No. 02/2025-26) Of The Company Scheduled To Be Held On Tuesday 05Th Day Of August 2025 Pursuant To Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Jul 28, 2025
Jul 28, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 04, 2025
Jul 04, 2025Closure of Trading WindowJun 26, 2025
Jun 26, 2025Intimation Of Receipts Of Work Completion CertificateJun 16, 2025
Jun 16, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 27, 2025
May 27, 2025Intimation To The Holders Of Physical Shares In Terms Of SEBI Circular No. SEBI/HO/MIRSD/MIRSD-Pod-1/P/CIR/2023/37 Dated March 16 2023 Regarding Mandatory Furnishing Of PAN KYC Details And Nomination.May 27, 2025
May 27, 2025Announcement Under Regulation 30 (LODR) Update In U. S. FDA Inspection Of Wholly Owned SubsidiaryMay 24, 2025
May 24, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 23, 2025
May 23, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMay 21, 2025
May 21, 2025Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended 31.03.2025May 21, 2025
May 21, 2025Board Meeting Outcome for HELD ON WEDNESDAY 21ST MAY 2025 PURSUANT TO REGULATION 30 OF SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS 2015.
May 21, 2025
May 21, 2025Board Meeting Intimation for Intimation For Meeting Of Board Of Directors (Serial No. 01/2025-26) Of The Company Scheduled To Be Held On Wednesday 21St Day Of May 2025 Pursuant To Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) RegMay 14, 2025
May 14, 2025Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 17, 2025
Apr 17, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 04, 2025
Apr 04, 2025Closure of Trading WindowMar 26, 2025
Mar 26, 2025Intimation Under Regulation 30 For Inspection Of U.S. FDA Of Wholly Owned SubsidiaryFeb 24, 2025
Feb 24, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 14, 2025
Feb 14, 2025Integrated Filing (Financial)Feb 12, 2025
Feb 12, 2025Unaudited Standalone And Consolidated Results For The Quarter 31.12.204Feb 12, 2025
Feb 12, 2025Board Meeting Outcome for OUTCOME OF BOARD MEETING HELD ON 12TH FEBRUARY 2025 PURSUANT TO REGULATION 30 OF SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS 2015Feb 12, 2025
Feb 12, 2025Board Meeting Intimation for Meeting Of Board Of Directors (Serial No. 04/2024-25) Of The Company Scheduled To Be Held On Wednesday 12Th Day Of February 2025 Pursuant To Regulation 29 Of SEBI (ListiFeb 03, 2025
Feb 03, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 07, 2025
Jan 07, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 14, 2024
Nov 14, 2024Un-Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended 30.09.2024Nov 12, 2024
Nov 12, 2024Board Meeting Outcome for OUTCOME OF BOARD MEETING HELD ON 12TH NOVEMBER, 2024 PURSUANT TO REGULATION 30 OF SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015.Nov 12, 2024
Nov 12, 2024Board Meeting Intimation for Intimation For Meeting Of Board Of Directors (Serial No. 03/2024-25) Of The Company, Scheduled To Be Held On Tuesday, 12Th Day Of November, 2024 Pursuant To Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.Nov 06, 2024
Nov 06, 2024Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 07, 2024
Oct 07, 2024Announcement under Regulation 30 (LODR)-Change in Registered Office AddressOct 03, 2024
Oct 03, 2024Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 27, 2024
Sep 27, 2024Shareholder Meeting / Postal Ballot-Outcome of AGMSep 26, 2024
Sep 26, 2024Closure of Trading WindowSep 26, 2024
Sep 26, 2024Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 04, 2024
Sep 04, 2024ANNOUNCEMENT UNDER REGULATION 44 OF SEBI (LODR) REGULATION, 2015Sep 02, 2024
Sep 02, 2024BOOK CLOSURE FOR 41ST ANNUAL GENERAL MEETING OF THE COMPANY.Sep 02, 2024
Sep 02, 2024Technical Indicators
RSI(14)
Neutral 39.50
ATR(14)
Less Volatile 2.17
STOCH(9,6)
Neutral 50.12
STOCH RSI(14)
Neutral 31.79
MACD(12,26)
Bearish -0.08
ADX(14)
Weak Trend 12.07
UO(9)
Bearish 51.84
ROC(12)
Downtrend And Accelerating -2.29
WillR(14)
Neutral -61.34
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
